Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.59 USD | +0.07% | +0.21% | +8.61% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 67.75 | 69.65 | 68.97 |
Spread/Res. | -0.24% | -2.96% | -2.00% |
Spread/Supp. | +1.68% | +8.72% | +17.40% |
Support | 66.47 | 62.17 | 57.57 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AXNX Stock
- Charts Axonics, Inc.